188 related articles for article (PubMed ID: 34708048)
1. A Review on the Carcinogenic Roles of DSCAM-AS1.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ebrahimzadeh K
Front Cell Dev Biol; 2021; 9():758513. PubMed ID: 34708048
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DSCAM-AS1 upregulates
Zhang S; Ding L; Gao F; Fan H
Biochem Cell Biol; 2020 Oct; 98(5):600-611. PubMed ID: 32379981
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis.
Liang J; Zhang S; Wang W; Xu Y; Kawuli A; Lu J; Xiu X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31737900
[TBL] [Abstract][Full Text] [Related]
4. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling.
Ning Y; Bai Z
Cancer Biomark; 2021; 30(1):29-39. PubMed ID: 32865178
[TBL] [Abstract][Full Text] [Related]
5. lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells.
Liu F; Jia J; Sun L; Yu Q; Duan H; Jiao D; Gong Z; Zhu S; Jiang K; He Y; Chen L; Zhang Y; Sun H
Onco Targets Ther; 2019; 12():6789-6795. PubMed ID: 31686837
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p.
Ji D; Hu G; Zhang X; Yu T; Yang J
Am J Transl Res; 2019; 11(7):4290-4302. PubMed ID: 31396335
[TBL] [Abstract][Full Text] [Related]
7. lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p.
Li L; Chen P; Huang B; Cai P
Oncol Lett; 2021 Dec; 22(6):825. PubMed ID: 34691252
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells.
Gao L; Chen X; Wang Y; Zhang J
Onco Targets Ther; 2020; 13():2725-2738. PubMed ID: 32280246
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis.
Zhang Y; Wang X; Wang P; Zhang X; Han SH; Huo F
Cell J; 2022 May; 24(5):222-229. PubMed ID: 35717565
[TBL] [Abstract][Full Text] [Related]
10. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
Chen H; Cai K
In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
[TBL] [Abstract][Full Text] [Related]
11. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
Qiu Z; Pan XX; You DY
Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DSCAM-AS1: A Pivotal Therapeutic Target in Cancer.
Hu C
Mini Rev Med Chem; 2023; 23(5):530-536. PubMed ID: 35996247
[TBL] [Abstract][Full Text] [Related]
14. A long non-coding RNA with important roles in the carcinogenesis.
Ghafouri-Fard S; Askari A; Hussen BM; Taheri M; Mokhtari M
Front Cell Dev Biol; 2022; 10():1037149. PubMed ID: 36467407
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
17. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
Ma Y; Bu D; Long J; Chai W; Dong J
J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
[TBL] [Abstract][Full Text] [Related]
18. DSCAM-AS1 promotes the development of prostate cancer.
Cheng L; Li S; Jiang D; Zhang J
Discov Oncol; 2024 Apr; 15(1):113. PubMed ID: 38605206
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136.
Huang YL; Xu Q; Wang X
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2888-2897. PubMed ID: 31002140
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
